On ECHEMI
Home > Drugs > Harbin Medical University Pharmaceutical Co., Ltd.
Harbin Medical University Pharmaceutical Co., Ltd.
  • Founded in:

    1998-04-08
  • Country:

    China China
  • Address:

    Bohai Road, Central Area, Haping Road, Harbin Development Zone
  • Tax NO.:

    91230199702953105L
  • Registered Funds:

    56.9258 million yuan
  • Website:

  • Email:

Related Drugs
Compound lidocaine hydrochloride injection
Name Description Content CAS NO. Registered Holders
Lidocaine hydrochloride

Compound lidocaine hydrochloride injection has an anesthetic effect

More

Compound lidocaine hydrochloride injection has an anesthetic effect

6108-05-0 45
Glipizide Capsules
The main ingredient of this product is: Glipizide. Its chemical name is: 1-cyclohexyl-3-{4-[2-(5-methylpyrazine-2-amide)-ethyl]benzenesulfonyl}urea.
Name Description Content CAS NO. Registered Holders
Glipizide

This product is a second-generation sulfonylurea oral hypoglycemic drug. It can promote the secretion of insulin by pancreatic beta cells and enhance the effect of insulin on target tissues; it can also stimulate pancreatic alpha cells to inhibit the secretion of glucagon, inhibit the decomposition of liver glycogen, and promote muscle utilization and consumption of glucose.

More

This product is a second-generation sulfonylurea oral hypoglycemic drug. It can promote the secretion of insulin by pancreatic beta cells and enhance the effect of insulin on target tissues; it can also stimulate pancreatic alpha cells to inhibit the secretion of glucagon, inhibit the decomposition of liver glycogen, and promote muscle utilization and consumption of glucose.

29094-61-9 26
Papaverine Hydrochloride for Injection
1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline hydrochloride
Name Description Content CAS NO. Registered Holders
Papaverine hydrochloride

It has a relaxant effect on visceral and vascular smooth muscles, directly inhibiting abnormal tension and spasm of smooth muscles, especially the spasmodic contraction of smooth muscles.

More

It has a relaxant effect on visceral and vascular smooth muscles, directly inhibiting abnormal tension and spasm of smooth muscles, especially the spasmodic contraction of smooth muscles.

61-25-6 15
Ergotamine Mesylate for Injection
Dihydroergoceptin mesylate is composed of equal proportions of dihydroergocornine mesylate, dihydroergocryptine mesylate (there are two isomers, dihydro-α-ergocryptine mesylate and dihydro-β-ergocryptine mesylate, in a ratio of 2:1) and dihydroergoline mesylate.
Name Description Content CAS NO. Registered Holders
Dihydroergotoxine mesylate

It changes the central nervous system signal transmission, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors; has a blocking effect on α-adrenergic receptors; improves damaged brain metabolic function; shortens cerebral circulation time; improves age-related intellectual decline symptoms (such as self-care, social behavior, emotional state and intellectual behavior); stabilizes cerebral vascular tension and prevents migraines.

More

It changes the central nervous system signal transmission, has an stimulatory effect on dopamine receptors and 5-hydroxytryptamine receptors; has a blocking effect on α-adrenergic receptors; improves damaged brain metabolic function; shortens cerebral circulation time; improves age-related intellectual decline symptoms (such as self-care, social behavior, emotional state and intellectual behavior); stabilizes cerebral vascular tension and prevents migraines.

8067-24-1 12
Dihydroergocornine mesylate

As one of the components of dihydroergotamine mesylate, it works together to exert the above-mentioned pharmacological effects.

More

As one of the components of dihydroergotamine mesylate, it works together to exert the above-mentioned pharmacological effects.

0
Dihydroergocryptine mesylate

As one of the components of dihydroergocryptine mesylate, it plays the above pharmacological effects together. It contains two isomers: dihydro-α-ergocryptine mesylate and dihydro-β-ergocryptine mesylate, with a ratio of 2:1.

More

As one of the components of dihydroergocryptine mesylate, it plays the above pharmacological effects together. It contains two isomers: dihydro-α-ergocryptine mesylate and dihydro-β-ergocryptine mesylate, with a ratio of 2:1.

0
Dihydroergoline mesylate

As one of the components of dihydroergotamine mesylate, it works together to exert the above-mentioned pharmacological effects.

More

As one of the components of dihydroergotamine mesylate, it works together to exert the above-mentioned pharmacological effects.

0
Netilmicin Sulfate for Injection
The main ingredient of this product is netilmicin sulfate, whose chemical name is O-3-deoxy C-methyl-3-methylamino-beta;-L-arabinopyranosyl (1rarr;4)-O[2,6-diamino-2,3,4,6-tetradeoxy-alpha;-D-glyceryl-4-enehexopyranosyl-(1rarr;6)]-2-deoxy-N3-ethyl-L-streptamine sulfate.
Name Description Content CAS NO. Registered Holders
Netilmicin sulfate

Netilmicin is a semi-synthetic aminoglycoside broad-spectrum antibiotic. Its mechanism of action is to inhibit the normal protein synthesis of sensitive microorganisms. This product has a wide range of antimicrobial effects, mainly targeting Gram-negative rods and a few Gram-positive bacteria, including Citrobacter, Enterobacter, Escherichia coli, Klebsiella, Morgan Proteus, Pseudomonas aeruginosa, Salmonella, Shigella and Staphylococcus (penicillin- and methicillin-resistant). This product is also active in vitro against some isolated Acinetobacter, Neisseria, indole-positive Proteus, Pseudomonas, and Serratia. Most streptococci and anaerobic microorganisms such as Clostridium are resistant to aminoglycosides.

More

Netilmicin is a semi-synthetic aminoglycoside broad-spectrum antibiotic. Its mechanism of action is to inhibit the normal protein synthesis of sensitive microorganisms. This product has a wide range of antimicrobial effects, mainly targeting Gram-negative rods and a few Gram-positive bacteria, including Citrobacter, Enterobacter, Escherichia coli, Klebsiella, Morgan Proteus, Pseudomonas aeruginosa, Salmonella, Shigella and Staphylococcus (penicillin- and methicillin-resistant). This product is also active in vitro against some isolated Acinetobacter, Neisseria, indole-positive Proteus, Pseudomonas, and Serratia. Most streptococci and anaerobic microorganisms such as Clostridium are resistant to aminoglycosides.

56391-57-2 4
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.